Cargando…

Bipolar versus monopolar transurethral resection of the prostate for benign prostatic hyperplasia: safe in patients with high surgical risk

Here, we compared the effects of bipolar and monopolar transurethral resection of the prostate (B-TURP, M-TURP) for treating elderly patients (≥75 years) with benign prostatic hyperplasia(BPH) who had internal comorbidities. Eligible BPH patients were aged ≥75 years and had at least one internal com...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Er J., Li, Hao, Sun, Xin B., Huang, Li, Wang, Li, Gong, Xiao X., Yang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759597/
https://www.ncbi.nlm.nih.gov/pubmed/26892901
http://dx.doi.org/10.1038/srep21494
_version_ 1782416754980421632
author Yang, Er J.
Li, Hao
Sun, Xin B.
Huang, Li
Wang, Li
Gong, Xiao X.
Yang, Yong
author_facet Yang, Er J.
Li, Hao
Sun, Xin B.
Huang, Li
Wang, Li
Gong, Xiao X.
Yang, Yong
author_sort Yang, Er J.
collection PubMed
description Here, we compared the effects of bipolar and monopolar transurethral resection of the prostate (B-TURP, M-TURP) for treating elderly patients (≥75 years) with benign prostatic hyperplasia(BPH) who had internal comorbidities. Eligible BPH patients were aged ≥75 years and had at least one internal comorbidity. In this open-label, prospective trial, patients were assigned to B-TURP (n = 75) and M-TURP (n = 88) groups. Data on prostate volume (PV), urination, and time during perioperative period were compared; data associated with urination and complications at one year postoperatively were also compared. Finally, follow-up data were available for 68 and 81 patients in the B-TURP and M-TURP group, respectively. No deaths were recorded. Intraoperative bleeding was lower and irrigation time, indwelling catheter time, and hospital stay were shorter in the B-TURP group than in the M-TURP group (p < 0.001). No difference was observed with respect to operation time (p = 0.058). At one year after the operation, differences with respect to urination and complications were not significant. In conclusion, Short-term efficacy of B-TURP or M-TURP was satisfactory for elderly patients with BPH who had internal comorbidities. Besides, B-TURP is a more sensible choice because it has a lower prevalence of adverse effects.
format Online
Article
Text
id pubmed-4759597
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47595972016-02-29 Bipolar versus monopolar transurethral resection of the prostate for benign prostatic hyperplasia: safe in patients with high surgical risk Yang, Er J. Li, Hao Sun, Xin B. Huang, Li Wang, Li Gong, Xiao X. Yang, Yong Sci Rep Article Here, we compared the effects of bipolar and monopolar transurethral resection of the prostate (B-TURP, M-TURP) for treating elderly patients (≥75 years) with benign prostatic hyperplasia(BPH) who had internal comorbidities. Eligible BPH patients were aged ≥75 years and had at least one internal comorbidity. In this open-label, prospective trial, patients were assigned to B-TURP (n = 75) and M-TURP (n = 88) groups. Data on prostate volume (PV), urination, and time during perioperative period were compared; data associated with urination and complications at one year postoperatively were also compared. Finally, follow-up data were available for 68 and 81 patients in the B-TURP and M-TURP group, respectively. No deaths were recorded. Intraoperative bleeding was lower and irrigation time, indwelling catheter time, and hospital stay were shorter in the B-TURP group than in the M-TURP group (p < 0.001). No difference was observed with respect to operation time (p = 0.058). At one year after the operation, differences with respect to urination and complications were not significant. In conclusion, Short-term efficacy of B-TURP or M-TURP was satisfactory for elderly patients with BPH who had internal comorbidities. Besides, B-TURP is a more sensible choice because it has a lower prevalence of adverse effects. Nature Publishing Group 2016-02-19 /pmc/articles/PMC4759597/ /pubmed/26892901 http://dx.doi.org/10.1038/srep21494 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Yang, Er J.
Li, Hao
Sun, Xin B.
Huang, Li
Wang, Li
Gong, Xiao X.
Yang, Yong
Bipolar versus monopolar transurethral resection of the prostate for benign prostatic hyperplasia: safe in patients with high surgical risk
title Bipolar versus monopolar transurethral resection of the prostate for benign prostatic hyperplasia: safe in patients with high surgical risk
title_full Bipolar versus monopolar transurethral resection of the prostate for benign prostatic hyperplasia: safe in patients with high surgical risk
title_fullStr Bipolar versus monopolar transurethral resection of the prostate for benign prostatic hyperplasia: safe in patients with high surgical risk
title_full_unstemmed Bipolar versus monopolar transurethral resection of the prostate for benign prostatic hyperplasia: safe in patients with high surgical risk
title_short Bipolar versus monopolar transurethral resection of the prostate for benign prostatic hyperplasia: safe in patients with high surgical risk
title_sort bipolar versus monopolar transurethral resection of the prostate for benign prostatic hyperplasia: safe in patients with high surgical risk
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759597/
https://www.ncbi.nlm.nih.gov/pubmed/26892901
http://dx.doi.org/10.1038/srep21494
work_keys_str_mv AT yangerj bipolarversusmonopolartransurethralresectionoftheprostateforbenignprostatichyperplasiasafeinpatientswithhighsurgicalrisk
AT lihao bipolarversusmonopolartransurethralresectionoftheprostateforbenignprostatichyperplasiasafeinpatientswithhighsurgicalrisk
AT sunxinb bipolarversusmonopolartransurethralresectionoftheprostateforbenignprostatichyperplasiasafeinpatientswithhighsurgicalrisk
AT huangli bipolarversusmonopolartransurethralresectionoftheprostateforbenignprostatichyperplasiasafeinpatientswithhighsurgicalrisk
AT wangli bipolarversusmonopolartransurethralresectionoftheprostateforbenignprostatichyperplasiasafeinpatientswithhighsurgicalrisk
AT gongxiaox bipolarversusmonopolartransurethralresectionoftheprostateforbenignprostatichyperplasiasafeinpatientswithhighsurgicalrisk
AT yangyong bipolarversusmonopolartransurethralresectionoftheprostateforbenignprostatichyperplasiasafeinpatientswithhighsurgicalrisk